Related Experiment Video
Updated: Jun 20, 2026

Labeling F-actin Barbed Ends with Rhodamine-actin in Permeabilized Neuronal Growth Cones
Published on: March 17, 2011
Abstract:
Bortezomib shows high activity in light chain amyloidosis. Responses occur rapidly and are seen in cardiac, renal, and hepatic disease. Toxicity in this fragile population is significant.
Insights
Bortezomib is highly active in treating light chain amyloidosis, with rapid responses observed in heart, kidney, and liver disease. However, this fragile patient group experiences significant toxicity.
Area of Science:
- Hematology
- Oncology
- Nephrology
Background:
- Light chain amyloidosis (AL) is a rare plasma cell disorder.
- Bortezomib is a proteasome inhibitor used in multiple myeloma treatment.
Discussion:
- Bortezomib demonstrates significant efficacy in AL amyloidosis, impacting multiple organ systems.
- Rapid responses are achievable, suggesting a role for early intervention.
Key Insights:
- Bortezomib exhibits high activity in light chain amyloidosis.
- Therapeutic responses are observed across cardiac, renal, and hepatic manifestations.
- Significant toxicity necessitates careful management in this vulnerable population.
Outlook:
- Further research is needed to optimize bortezomib dosing and management strategies.
- Investigating combination therapies may improve efficacy and mitigate toxicity.
Related Concept Videos
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Disassembly of Intermediate Filaments
Keratin proteins, found at the cell periphery near cell junctions, undergo a cycle of assembly and disassembly. In Type...
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
Generation of Straight or Branched Actin Filaments
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...
Clot Retraction and Fibrinolysis
Formation of Intermediate Filaments

